US Biotest
Closed portfolio with an early-phase archive tilt
According to ClinicalTrials.gov-derived indexes, US Biotest sits in the upper quartile of US sponsors by registered trial count (#2,913 of 15,742 sponsors by registered trial count).
US Biotest: 4 sponsored US clinical trials, none currently recruiting.
US Biotest sponsors 4 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 2 completed. 0 of these trials are in Phase 3-4 (later-stage) and 4 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Foot Ulcer, Diabetic, with 1 trials.
Upper-quartile sponsor footprint
US Biotest sits in the upper quartile of the sponsor corpus (#2,913 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.
Indexed trials (enrollment closed)
4 total, page 1 of 1
Safety and Efficacy of USB002 for Respiratory Distress Due to COVID-19
NCT04778059
Study of the Safety of USB005 in Healthy Volunteers
NCT03615196
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
NCT00796744
Safety Study of TXA127 to Elevate CD4+ T-Lymphocyte Counts in HIV-Infected Patients on Stable HAART Therapy
NCT00757250
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 2 |
Therapeutic Areas
How the US Biotest early-phase archive is shaped
4 indexed studies, none listed as recruiting (0% open); 2 completed (50%).
Phase mix: 0 late (III/IV) vs 4 early (I/II) (early-phase heavy).
Top condition: Foot Ulcer, Diabetic (1 trial), 1 other listed.
How to read a closed sponsor archive
When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.
US Biotest: archived-pipeline peers nationwide
Peers matched on 4 indexed studies with no current recruiting: volume and archive shape, not condition overlap.
US Biotest sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 4 archived trials
- 4D pharma · 4 trials · 0% recruiting
- 60 Degrees Pharmaceuticals · 4 trials · 50% recruiting
- A2 Biotherapeutics · 4 trials · 75% recruiting
- Abdul Latif Jameel Poverty Action Lab · 4 trials · 25% recruiting
Sponsors with similar archive density (± trial count)
- 10xBio · 0% recruiting · 3 trials
- 22nd Century Group · 0% recruiting · 3 trials
- 23andMe · 0% recruiting · 6 trials
- 3-C Institute for Social Development · 0% recruiting · 14 trials
Related
What to do with this US Biotest page
4 registered trials is a research-attention snapshot, not an endorsement of US Biotest or any single study.
- None of US Biotest's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
- Foot Ulcer, Diabetic is the condition US Biotest studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Foot Ulcer, Diabetic trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
US Biotest pipeline card: 4 registered trials from official public datasets.Report a data error.